Trials / Completed
CompletedNCT06507566
Evaluating Technologies for Point-of-Care Blood Collections by Patients
Phase 1 Study Evaluating Technologies for Point-of-Care Blood Collections in Support of Decentralized Outpatient Assessments in Pandemic and Clinical Trial Settings
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Alachua Government Services, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A study evaluating technologies for point-of-care use in clinical trials.
Detailed description
A study evaluating the Tasso+ blood collection device that enables the safe and convenient collection of blood by a lay person (eg, patient or study participant) under the supervision of an Health Care Provider.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tasso+™ | The Tasso+™ blood collection kit is a collection device (called the Tasso+™) and a capillary collection tube that allows for the storage of the blood in a liquid format in different matrices. |
Timeline
- Start date
- 2024-10-29
- Primary completion
- 2025-04-04
- Completion
- 2025-04-04
- First posted
- 2024-07-18
- Last updated
- 2026-01-23
- Results posted
- 2026-01-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06507566. Inclusion in this directory is not an endorsement.